# ClinicalTrials.gov record NCT04879420

> PeptideScanner retained ClinicalTrials.gov record NCT04879420 at 2026-07-30T19:10:42.715Z. Its registry update date was 2023-07-27, and PeptideScanner's reviewed identity mapping was teriparatide.

- Evidence object: `story:clinicaltrials-gov-nct04879420-teriparatide:v1`
- Evidence domain: Clinical trials
- Date in source: 2023-07-27
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct04879420-teriparatide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct04879420-teriparatide-v1.json
- Content SHA-256: `60f5f3e9ed7eb73d041508264b821e185c669cd47b9b9dc9640c464228a52f23`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT04879420 ([`ctg-observation-nct04879420-2023-07-27-e9caa19827c7`](#source-ctg-observation-nct04879420-2023-07-27-e9caa19827c7))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT04879420 at 2026-07-30T19:10:42.715Z. Its registry update date was 2023-07-27, and PeptideScanner's reviewed identity mapping was teriparatide. ([`ctg-observation-nct04879420-2023-07-27-e9caa19827c7`](#source-ctg-observation-nct04879420-2023-07-27-e9caa19827c7))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT04879420 at 2026-07-30T19:10:42.715Z. Its registry update date was 2023-07-27, and PeptideScanner's reviewed identity mapping was teriparatide. ([`ctg-observation-nct04879420-2023-07-27-e9caa19827c7`](#source-ctg-observation-nct04879420-2023-07-27-e9caa19827c7))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct04879420-2023-07-27-e9caa19827c7`](#source-ctg-observation-nct04879420-2023-07-27-e9caa19827c7))

## Sources

<a id="source-ctg-observation-nct04879420-2023-07-27-e9caa19827c7"></a>
- **ClinicalTrials.gov record NCT04879420 · retained source version 2023-07-27:e9caa19827c7cf806fba08ac238c1422e87cddd48b6b37e9dfc79becf0df455c** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT04879420) (`ctg-observation-nct04879420-2023-07-27-e9caa19827c7`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT04879420." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct04879420-teriparatide-v1.json SHA-256: 60f5f3e9ed7eb73d041508264b821e185c669cd47b9b9dc9640c464228a52f23.